This topic contains a solution. Click here to go to the answer

Author Question: You may talk to the jury a. during the trial. b. before the trial. c. after the trial. d. You ... (Read 98 times)

notis

  • Hero Member
  • *****
  • Posts: 596
You may talk to the jury
 
  a. during the trial.
  b. before the trial.
  c. after the trial.
  d. You can't ever talk to the jury.

Question 2

The first warning date for trial preparation is ordinarily
 
  a. 120 days before trial.
  b. 90 days before trial.
  c. 30 days before trial.
  d. 14 days before trial.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Alyson.hiatt@yahoo.com

  • Sr. Member
  • ****
  • Posts: 354
Answer to Question 1

c

Answer to Question 2

b





 

Did you know?

Signs and symptoms that may signify an eye tumor include general blurred vision, bulging eye(s), double vision, a sensation of a foreign body in the eye(s), iris defects, limited ability to move the eyelid(s), limited ability to move the eye(s), pain or discomfort in or around the eyes or eyelids, red or pink eyes, white or cloud spots on the eye(s), colored spots on the eyelid(s), swelling around the eyes, swollen eyelid(s), and general vision loss.

Did you know?

Common abbreviations that cause medication errors include U (unit), mg (milligram), QD (every day), SC (subcutaneous), TIW (three times per week), D/C (discharge or discontinue), HS (at bedtime or "hours of sleep"), cc (cubic centimeters), and AU (each ear).

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library